Parkinson's Disease - Feb 20, 2018 Edition

Health News and Information - News Medical

February 20, 2018     Parkinson's Disease     The latest Parkinson's disease news from News Medical

Researchers develop new method to map dopamine system in Parkinson's patients   With the aid of a PET camera, researchers from Karolinska Institutet in Sweden have developed a new method for investigating the dopamine system in the brains of patients suffering from Parkinson's disease.

NIH scientists modify new RT-QuIC assay to detect Parkinson's, dementia with Lewy bodies   National Institutes of Health scientists developing a rapid, practical test for the early diagnosis of prion diseases have modified the assay to offer the possibility of improving early diagnosis of Parkinson's disease and dementia with Lewy bodies.         Researchers uncover how excess calcium may influence development of Parkinson’s disease   Researchers have found that excess levels of calcium in brain cells may lead to the formation of toxic clusters that are the hallmark of Parkinson's disease.

Traces of caffeine and its byproducts in the blood can be indicative of Parkinson’s disease   Researchers at Juntendo University report in Neurology the potential use of blood levels of caffeine and its byproducts as biomarkers for Parkinson’s disease. The finding is promising for the development of a method enabling early identification of the disease.       New family of peptides in wasp's venom may help develop better Parkinson's treatments   After being stung by a parasitic wasp, the American cockroach loses control of its behavior, becoming host to the wasp's egg.       Therapeutic target for glaucoma could have treatment ramifications for Alzheimer’s and Parkinson’s   A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findings released today in the Proceedings of the National Academy of Sciences.       New study to test safety, efficacy of MRI-guided focused ultrasound to treat Parkinson's disease   University of Maryland Medicine is leading a phase 3 study to test the safety and efficacy of using MRI-guided focused ultrasound on the brain in order to treat Parkinson's disease.

Website: www.news-medical.net Email: info@news-medical.net Telephone: +44 (0)161 457 7150 AZoNetwork UK Ltd. NEO, 4th Floor 9 Charlotte Street, Manchester M1 4ET, UK